RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-7.57%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.97B
AUM Growth
+$3.97B
(-8.2%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
30.63%
Holding
141
New
5
Increased
76
Reduced
8
Closed
5
Top Buys
| 1 |
DexCom
DXCM
|
$24.2M |
| 2 |
Idexx Laboratories
IDXX
|
$21.2M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$18.1M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$12.8M |
| 5 |
Penumbra
PEN
|
$12.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$18.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.6M |
| 3 |
Immuneering
IMRX
|
$17.6M |
| 4 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$13M |
| 5 |
XENT
Intersect ENT, Inc
XENT
|
$10.9M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Consumer Staples | 1.53% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$58.6B
| $54.3M | 1.37% |
332,500
| – | – |
|
|
27
DexCom
DXCM
$30.9B
| $53.2M | 1.34% |
416,000
+189,000
| +83% | +$24.2M |
|
28
Zai Lab
ZLAB
$3.48B
| $53M | 1.34% |
1,205,900
+25,200
| +2% | +$1.11M |
|
|
NVRO
29
DELISTED
NEVRO CORP.
NVRO
| $52.2M | 1.31% |
721,500
+7,500
| +1% | +$542K |
|
30
Acadia Healthcare
ACHC
$2.15B
| $49.4M | 1.24% |
753,500
+5,000
| +0.7% | +$328K |
|
31
Ascendis Pharma
ASND
$12.1B
| $49M | 1.23% |
417,500
+17,500
| +4% | +$2.05M |
|
|
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $46M | 1.16% |
559,734
+149,319
| +36% | +$12.3M |
|
|
33
Penumbra
PEN
$10.5B
| $45.4M | 1.14% |
204,500
+56,000
| +38% | +$12.4M |
|
34
Exact Sciences
EXAS
$9.33B
| $39.9M | 1% |
570,000
| – | – |
|
|
SGEN
35
DELISTED
Seagen Inc. Common Stock
SGEN
| $39M | 0.98% |
270,500
+14,500
| +6% | +$2.09M |
|
|
SRRA
36
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $37.7M | 0.95% |
1,174,786
-10,007
| -0.8% | -$321K |
|
37
Mirum Pharmaceuticals
MIRM
$3.75B
| $36.7M | 0.92% |
1,666,208
+127,394
| +8% | +$2.81M |
|
38
Encompass Health
EHC
$12.5B
| $35.7M | 0.9% |
631,643
| – | – |
|
39
Warby Parker
WRBY
$3.08B
| $35.1M | 0.88% |
1,038,500
+314,500
| +43% | +$10.6M |
|
40
Sarepta Therapeutics
SRPT
$1.98B
| $33.4M | 0.84% |
428,000
+4,000
| +0.9% | +$312K |
|
41
Novavax
NVAX
$1.2B
| $33M | 0.83% |
448,200
+23,200
| +5% | +$1.71M |
|
42
Kymera Therapeutics
KYMR
$3.1B
| $32M | 0.81% |
755,875
+13,810
| +2% | +$584K |
|
43
Arvinas
ARVN
$580M
| $30.8M | 0.78% |
457,600
+400
| +0.1% | +$26.9K |
|
44
CONMED
CNMD
$1.64B
| $30.1M | 0.76% |
202,500
| – | – |
|
45
West Pharmaceutical
WST
$17.9B
| $28.4M | 0.72% |
69,250
+23,750
| +52% | +$9.75M |
|
|
CVET
46
DELISTED
Covetrus, Inc. Common Stock
CVET
| $28.1M | 0.71% |
1,675,000
+13,300
| +0.8% | +$223K |
|
47
Madrigal Pharmaceuticals
MDGL
$9.7B
| $26.8M | 0.68% |
273,500
+4,100
| +2% | +$402K |
|
|
NVTA
48
DELISTED
Invitae Corporation
NVTA
| $26.5M | 0.67% |
3,323,821
+523,578
| +19% | +$4.17M |
|
|
ACCD
49
DELISTED
Accolade, Inc. Common Stock
ACCD
| $26.4M | 0.67% |
1,505,000
+308,000
| +26% | +$5.41M |
|
|
ABCM
50
DELISTED
Abcam plc American Depositary Shares
ABCM
| $26.2M | 0.66% |
1,432,900
+180,400
| +14% | +$3.3M |
|